chlorzoxazone has been researched along with Cognitive Decline in 2 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chlorzoxazone (CZ) is a classical FDA-approved drug, and shows anti-inflammatory effects." | 5.56 | Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo. ( Bai, Y; Ma, X, 2020) |
| "Chlorzoxazone (CZ) is a classical FDA-approved drug, and shows anti-inflammatory effects." | 1.56 | Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo. ( Bai, Y; Ma, X, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marinina, KS | 1 |
| Bezprozvanny, IB | 1 |
| Egorova, PA | 1 |
| Bai, Y | 1 |
| Ma, X | 1 |
2 other studies available for chlorzoxazone and Cognitive Decline
| Article | Year |
|---|---|
A chlorzoxazone-folic acid combination improves cognitive affective decline in SCA2-58Q mice.
Topics: Animals; Chlorzoxazone; Cognition; Cognitive Dysfunction; Mice; Mice, Transgenic; Spinocerebellar At | 2023 |
Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Astrocytes; Behavior, Animal; Cell D | 2020 |